10-Q/A XBRL

FORM 10-Q/A

Company: Lexaria Bioscience Corp.
Filed: January 18, 2023
Period of Report: November 30, 2022
Accession Number: 0001640334-23-000091

View Document ↗ View on SEC.gov ↗